BR112022009803A2 - Variantes de sacarose invertase - Google Patents

Variantes de sacarose invertase

Info

Publication number
BR112022009803A2
BR112022009803A2 BR112022009803A BR112022009803A BR112022009803A2 BR 112022009803 A2 BR112022009803 A2 BR 112022009803A2 BR 112022009803 A BR112022009803 A BR 112022009803A BR 112022009803 A BR112022009803 A BR 112022009803A BR 112022009803 A2 BR112022009803 A2 BR 112022009803A2
Authority
BR
Brazil
Prior art keywords
variants
sucrose invertase
sucrose
invertase
fructose
Prior art date
Application number
BR112022009803A
Other languages
English (en)
Inventor
Ko Nien-Hsi
Lau Wee Janice
A Hattendorf Douglas
Original Assignee
Corbion Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corbion Biotech Inc filed Critical Corbion Biotech Inc
Publication of BR112022009803A2 publication Critical patent/BR112022009803A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2431—Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/12—Disaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026—Beta-fructofuranosidase (3.2.1.26), i.e. invertase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A presente revelação fornece variantes de sacarose invertase que têm uma habilidade melhorada para hidrolisar sacarose em glicose e frutose e métodos e composições relacionados.
BR112022009803A 2019-11-20 2020-11-19 Variantes de sacarose invertase BR112022009803A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962937849P 2019-11-20 2019-11-20
US202062961986P 2020-01-16 2020-01-16
PCT/US2020/061280 WO2021102139A1 (en) 2019-11-20 2020-11-19 Sucrose invertase variants

Publications (1)

Publication Number Publication Date
BR112022009803A2 true BR112022009803A2 (pt) 2022-08-16

Family

ID=73854898

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022009803A BR112022009803A2 (pt) 2019-11-20 2020-11-19 Variantes de sacarose invertase

Country Status (4)

Country Link
US (1) US20230037413A1 (pt)
EP (1) EP4061936A1 (pt)
BR (1) BR112022009803A2 (pt)
WO (1) WO2021102139A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024015943A1 (en) * 2022-07-13 2024-01-18 Anagram Therapeutics, Inc. Methods and compositions for treating congenital sucrase-isomaltase deficiency

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110111413A1 (en) 2001-02-02 2011-05-12 Padgett Hal S Method of optimizing codon usage through dna shuffling
US20080292918A1 (en) 2007-05-25 2008-11-27 Caine Finnerty Electrochemical system having multiple independent circuits
MY154965A (en) 2007-06-01 2015-08-28 Solazyme Inc Production of oil in microorganisms
US20110045563A1 (en) 2008-02-06 2011-02-24 The Regents Of The University Of California Short chain volatile isoprene hydrocarbon production using the mevalonic acid pathway in genetically engineered yeast and fungi
US7632995B2 (en) 2008-05-09 2009-12-15 Monsanto Technology Llc Plants and seeds of hybrid corn variety CH852179
MX2011005630A (es) 2008-11-28 2011-09-28 Solazyme Inc Producción de aceites específicos en microorganismos heterótroficos recombinantes.
US20100297749A1 (en) 2009-04-21 2010-11-25 Sapphire Energy, Inc. Methods and systems for biofuel production
EP2477478B1 (en) 2009-09-15 2016-11-30 Sapphire Energy, Inc. A system for transformation of the chloroplast genome of scenedesmus sp. and dunaliella sp.
MX339639B (es) 2010-05-28 2016-06-02 Solazyme Inc * Aceites especificos producidos a partir de microorganismos heterotrofos recombinantes.
CN103608450A (zh) 2011-05-06 2014-02-26 索拉兹米公司 基因工程改造的代谢木糖的微生物
WO2013082186A2 (en) 2011-11-28 2013-06-06 Solazyme, Inc. Genetically engineered microbial strains including prototheca lipid pathway genes
EP3550025A1 (en) 2012-04-18 2019-10-09 Corbion Biotech, Inc. Tailored oils
EA038924B1 (ru) 2012-05-25 2021-11-10 Те Риджентс Оф Те Юниверсити Оф Калифорния Способы и композиции рнк-специфической модификации днк-мишени и рнк-специфической модуляции транскрипции
AU2014235794A1 (en) 2013-03-14 2015-10-22 Caribou Biosciences, Inc. Compositions and methods of nucleic acid-targeting nucleic acids
KR101520614B1 (ko) * 2013-07-25 2015-05-19 서울대학교산학협력단 당단백질의 탈당화 검출을 통한 암 진단 방법
AU2014331605A1 (en) 2013-10-04 2016-05-12 Corbion Biotech, Inc. Tailored oils
BR112017000414A2 (pt) 2014-07-10 2017-11-07 Terravia Holdings Inc genes cetoacil-acp sintase e utilizações dos mesmos
EP3194582A2 (en) 2014-09-18 2017-07-26 TerraVia Holdings, Inc. Acyl-acp thioesterases and mutants thereof
US20180142218A1 (en) 2016-10-05 2018-05-24 Terravia Holdings, Inc. Novel acyltransferases, variant thioesterases, and uses thereof

Also Published As

Publication number Publication date
WO2021102139A1 (en) 2021-05-27
US20230037413A1 (en) 2023-02-09
EP4061936A1 (en) 2022-09-28

Similar Documents

Publication Publication Date Title
MX2020006115A (es) Inhibidores de la vía de respuesta al estrés integrada.
PH12016501668A1 (en) Compositions and methods for the reduction or prevention of hepatic steatosis
BR112018004620A2 (pt) moduladores da expressão de kras
CL2020000946A1 (es) Métodos y composiciones para la producción de trifosfato de nucleosido y ácido ribonucleico
BR112018074468A2 (pt) anticorpos anti-cd40 e suas utilizações
BR112015019817A2 (pt) interface de vedação para um compartimento de telecomunicações
BR112019001602A2 (pt) composição de açúcar
PH12019550249A1 (en) Solid compositions for oral administration
BR112022003527A2 (pt) Cianopirrolidinas substituídas com atividade como inibidores de usp30
CL2020001543A1 (es) Constructos de arni para inhibir la expresión de pnpla3 y métodos de uso de los mismos.
BR112016006649A2 (pt) biscoito macio com glicose de liberação lenta
CL2020003074A1 (es) Inhibidores de la vía de respuesta al estrés integrada.
BR112018008960A8 (pt) estrutura de relatório de formação de feixe
BR112017008176A2 (pt) método de preparação do carbonato de ácido glicérico.
BR112016018063A2 (pt) Dispositivo de fixação, e, método de fixação de um primeiro substrato em um segundo substrato
BR112012026768A2 (pt) composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores.
BR112018010945A2 (pt) formulações com degradação de polissorbato reduzida
WO2016073763A3 (en) Beta-glucan methods and compositions that affect the tumor microenvironment
ECSP18018793A (es) Compuestos útiles para inhibir ror-gamma-t
CL2021001488A1 (es) Transposasa de piggybac mutada
BR112016017509A2 (pt) composições e métodos compreendendo uma variante da enzima xilanase
BR112022009803A2 (pt) Variantes de sacarose invertase
BR112021023144A2 (pt) Compostos de oxatiazina para inibir gapdh
BR112018077510A2 (pt) variantes de lipase e composições que compreendem tensoativo e variante de lipase
EP3502119A3 (en) Immunomodulating beta-1,6-d-glucans